Stock Market News Briefs: Bank Of America Corporation, CNF, Inc., H&R Block, Inc., Pfizer, Inc., Broadcom Corporation, Bucyrus International, Inc., China BAK Battery, Inc., Google Inc., Intel Corporation, Standard Microsystems Corporation, STEC, Inc., Volterra Semiconductor CorporationZacks Investmentupdated Dec 30, 2009TweetAt GET.com we maintain complete editorial integrity on our content & provide transparent & unbiased information. Companies don't pay us to include their products although we receive a compensation when you successfully apply to products from our partners. See how we make money here.At GET.com we maintain complete editorial integrity. STEC (STEC) shares moved higher for the tenth session, gaining on takeover speculation. Moreover, Broadpoint AmTech posted a "buy" rating on the shares with a $23 price target. Broadcom (BRCM) agreed to a $160.5 million proposed settlement of a class-action lawsuit concerning the back-dating of stock options after SEC complaints against the firm's CEO and CFO were dismissed by a California judge on claims the state prosecutors had intimidated three key witnesses. Bank of America (BAC) upgraded Con-Way (CNW) to "buy," increasing its price target to $45. Broadpoint AmTech reiterated its "buy" rating on Bucyrus (BUCY), and increased its 2010 earnings forecast with a price target of $75. The firm raised the 2010 estimate to $3.49 from $3.35, above Street estimates, although under management's qualitative guideline. A research note from Kaufman Brothers claims additional climbs in semiconductor shares are likely, noting that"we are incrementally constructive on holding the group given the likelihood of a move to the upside from essentially a range-bound performance since August." The analyst finds PC-exposed semi shares most attractive, including Intel (INTC), Volterra (VLTR) and Standard Microsystems (SMSC). Volterra and Standard Microsystems' price targets were lifted to $23 and $25, respectively, with Intel's retained at $25. Barrington Research upgraded H&R Block (HRB) from "market perform" to "outperform", with a $30 price target. China BAK Battery (CBAK) shares soared 64% on Tuesday following unsubstantiated rumors that the company will manufacture batteries to be used in Google's (GOOG) pending Nexus One smartphone. Pfizer (PFE) announced plans to discontinue its Phase 3 trial of figitumumab in non-small cell lung cancer for futility.Editorial Disclosure: Any personal views and opinions expressed by the author in this article are the author's own and do not necessarily reflect the viewpoint of GET.com. The editorial content on this page is not provided by any of the companies mentioned, and has not been reviewed, approved or otherwise endorsed by any of these entities. Opinions expressed here are author's alone, not those of the companies mentioned, and have not been reviewed, approved or otherwise endorsed by any of these entities.